Actually the outstanding share count was much lower than that at the end of Q2 per the Q2 filing. The latest update suggests that 39 million shares converted since the last update, however 55 million restricted shares cashed out reducing the number of the OS. So actually 94.4 shares converted since the last November 1st update. 509.5 million new shares for Q3 and 298.9 million new shares so far for Q4. LABRYS alone ensures that the the dilution will continue into the foreseeable future and at these lower prices the number of new shares will be increasing.
https://sec.report/Document/0001721868-21-000524/ Authorized and outstanding [color=red]The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,601,515,456 and 2,027,085,665 shares of common stock at June 30, 2021 and December 31, 2020, respectively.[/color]
Taking the share price and multiplying it by the outstanding share count is such a red herring argument. Market cap is pure conjecture in these situations. You guys do realize that if the authorized share count was maxed out at 10 billion, and the share price hit bottom at .0001, that your market cap would be $1 million. Keep selling shares at .0001 and when you hit 40 billion outstanding shares you again have a market cap of $4 million? Still under valued?
Market Data 
Markets 
AI
